Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
forodesine | purine nucleoside phosphorylase | small molecule | Clinical trial target | TTD , drugbank , DGIDB | leukemia[MeSHID:D007938] Lymphoma[MeSHID:D008223] Lymph[MeSHID:D008196] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] T-Cell Cutaneous[MeSHID:D016410] Burkitt Lymphoma[MeSHID:D002051] |
76.38 | investigational,phase 1/2 | inhibitor |
forodesine | purine nucleoside phosphorylase | small molecule | Clinical trial target | TTD , drugbank , DGIDB | leukemia[MeSHID:D007938] Lymphoma[MeSHID:D008223] Lymph[MeSHID:D008196] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] T-Cell Cutaneous[MeSHID:D016410] Burkitt Lymphoma[MeSHID:D002051] |
76.38 | investigational,phase 1/2 | unknown |
click here to return to the previous page |